Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...
Citi Annual Global Healthcare Conference 2025 December 3, 2025 1:00 PM ESTCompany ParticipantsEliav Barr - Chief Medical ...
New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.
Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...
Quincy Bioscience exemplifies the concept that many breakthroughs in biotechnology can be inspired by discoveries made in ...
Background Complete revascularisation has been associated with improved short-term outcomes in patients with coronary artery ...
Invest in diverse CRE types, as sectors like industrial and retail show varying demand and yield. Research local markets extensively to avoid investing in oversupplied or declining sectors. Understand ...